See how top analysts and institutions rate AAPL — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Wells Fargo | Reiterated | Overweight | $245 → $290 | 2025-10-21 |
| Goldman | Reiterated | Buy | $266 → $279 | 2025-10-21 |
| Loop Capital | Upgrade | Hold → Buy | $315 | 2025-10-20 |
| Jefferies | Downgrade | Hold → Underperform | $205.16 | 2025-10-03 |
| Morgan Stanley | Reiterated | Overweight | $240 → $298 | 2025-10-02 |
| Seaport Research Partners | Initiated | Buy | $310 | 2025-10-01 |
| Evercore ISI | Reiterated | Outperform | $260 → $290 | 2025-09-26 |
| Wedbush | Reiterated | Outperform | $270 → $310 | 2025-09-22 |
| JP Morgan | Reiterated | Overweight | $255 → $280 | 2025-09-19 |
| Bernstein | Initiated | Outperform | $290 | 2025-09-16 |
| DA Davidson | Downgrade | Buy → Neutral | $250 | 2025-09-11 |
| MoffettNathanson | Upgrade | Sell → Neutral | $225 | 2025-09-04 |
| Loop Capital | Reiterated | Hold | $230 → $226 | 2025-08-21 |
| BofA Securities | Reiterated | Buy | $240 → $250 | 2025-08-07 |
| BofA Securities | Reiterated | Buy | $235 → $240 | 2025-08-01 |
| Citigroup | Reiterated | Buy | $240 → $245 | 2025-08-01 |
| UBS | Reiterated | Neutral | $210 → $220 | 2025-08-01 |
| JP Morgan | Reiterated | Overweight | $250 → $255 | 2025-08-01 |
| Morgan Stanley | Reiterated | Overweight | $235 → $240 | 2025-08-01 |
| Monness Crespi & Hardt | Reiterated | Buy | $245 → $270 | 2025-08-01 |
| Barclays | Reiterated | Underweight | $173 → $180 | 2025-08-01 |
| Raymond James | Reiterated | Outperform | $230 → $240 | 2025-08-01 |
| Jefferies | Upgrade | Underperform → Hold | $188.32 | 2025-07-02 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| December 2025 | 5 | 24 | 15 | 1 | 3 |
| November 2025 | 5 | 24 | 15 | 1 | 3 |
| October 2025 | 5 | 24 | 15 | 1 | 3 |
| September 2025 | 5 | 23 | 15 | 1 | 3 |
The majority of institutional investors have issued a "Buy" rating for AAPL, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
